| No (%) of patients or mean ± SD |  | |
---|---|---|---|
 | Pre | Post | Overall |
Patient characteristics | n=670 | n=609 | n=1,279 |
Gender | Â | Â | Â |
• Female | 341 (50.9) | 309 (50.7) | 650 (50.8) |
• Male | 329 (49.1) | 300 (49.3) | 629 (49.2) |
Age | Â | Â | Â |
• <65 | 276 (41.2) | 282 (46.3) | 558 (43.6) |
• ≥65 | 394 (58.8) | 327 (53.7) | 721 (53.4) |
Co-morbidities | Â | Â | Â |
• Cardiovascular | 45 (6.7) | 40 (6.6) | 95 (7.4) |
• Renal | 10 (1.5) | 7 (1.2) | 17 (1.3) |
Drugs | |||
Number of oral hypoglycemic agents | Â | Â | Â |
• 1 | 610 (91.0) | 567 (93.1) | 1177 (92.0) |
• ≥2 | 60 (9.0) | 42 (6.9) | 102 (8.0) |
Physician characteristics | n=95 | n=73 | n=111 |
Gender | Â | Â | Â |
• Female | 45 (47.4) | 30 (41.1) | 51 (45.9) |
• Male | 50 (52.6) | 43 (58.9) | 60 (54.1) |
Practice experience (in years) (mean, SD) | 22 (8.1) | 23.4 (7.6) | 21.95 (8.08) |
Evidence score | n=83 | n=68 | n=92 |
(mean, SD) | 21.1 (2.4) | 21.2 (2.5) | 21.2 (2.51) |
• <20 | 20 (24.7) | 18 (26.5) | 23 (25.0) |
• 20-23 | 49 (60.5) | 38 (55.9) | 54 (58.7) |
• >23 | 12 (14.8) | 12 (17.7) | 15 (16.3) |